Publisher: Icon Group International, Inc.
Category: Oncology/Hematology

Oncology/Hematology market research reports by Icon Group International, Inc.

(361 reports matching your criteria)
    • The 2025-2030 World Outlook for Breast Cancer Screenings

      The 2025-2030 World Outlook for Breast Cancer Screenings This study covers the world outlook for breast cancer screenings across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millio ... Read More

    • The 2025-2030 World Outlook for Esophageal Cancer Monoclonal Antibodies (mAb)

      The 2025-2030 World Outlook for Esophageal Cancer Monoclonal Antibodies (mAb) This study covers the world outlook for esophageal cancer monoclonal antibodies (mAb) across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E ... Read More

    • The 2025-2030 World Outlook for Prostate Cancer Diagnostics

      The 2025-2030 World Outlook for Prostate Cancer Diagnostics This study covers the world outlook for prostate cancer diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in ... Read More

    • The 2025-2030 World Outlook for Prostate Cancer Nuclear Medicine Diagnostics

      The 2025-2030 World Outlook for Prostate Cancer Nuclear Medicine Diagnostics This study covers the world outlook for prostate cancer nuclear medicine diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.) ... Read More

    • The 2025-2030 World Outlook for Cancer Profiling and Pathways

      The 2025-2030 World Outlook for Cancer Profiling and Pathways This study covers the world outlook for cancer profiling and pathways across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question ... Read More

    • The 2025-2030 World Outlook for Cancer and Tumor Profiling

      The 2025-2030 World Outlook for Cancer and Tumor Profiling This study covers the world outlook for cancer and tumor profiling across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mi ... Read More

    • The 2025-2030 World Outlook for Gynaecological Cancer Drugs

      The 2025-2030 World Outlook for Gynaecological Cancer Drugs This study covers the world outlook for gynaecological cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in ... Read More

    • The 2025-2030 World Outlook for Gynecologic Oncology

      The 2025-2030 World Outlook for Gynecologic Oncology This study covers the world outlook for gynecologic oncology across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U. ... Read More

    • The 2025-2030 World Outlook for Radiology Oncology Surgical Robots Devices

      The 2025-2030 World Outlook for Radiology Oncology Surgical Robots Devices This study covers the world outlook for radiology oncology surgical robots devices across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo ... Read More

    • The 2025-2030 World Outlook for Cancer Biologics

      The 2025-2030 World Outlook for Cancer Biologics This study covers the world outlook for cancer biologics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dolla ... Read More

    • The 2025-2030 World Outlook for Cancer Liquid Biopsy Products

      The 2025-2030 World Outlook for Cancer Liquid Biopsy Products This study covers the world outlook for cancer liquid biopsy products across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question ... Read More

    • The 2025-2030 World Outlook for Cancer Pain

      The 2025-2030 World Outlook for Cancer Pain This study covers the world outlook for cancer pain across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the p ... Read More

    • The 2025-2030 World Outlook for Cancer Pain Management

      The 2025-2030 World Outlook for Cancer Pain Management This study covers the world outlook for cancer pain management across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More

    • The 2025-2030 World Outlook for Head and Neck Cancer Diagnostics

      The 2025-2030 World Outlook for Head and Neck Cancer Diagnostics This study covers the world outlook for head and neck cancer diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in que ... Read More

    • The 2025-2030 World Outlook for Colorectal Cancer Chemotherapy Therapeutics

      The 2025-2030 World Outlook for Colorectal Cancer Chemotherapy Therapeutics This study covers the world outlook for colorectal cancer chemotherapy therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), ... Read More

    • The 2025-2030 World Outlook for Breast Cancer Liquid Biopsies

      The 2025-2030 World Outlook for Breast Cancer Liquid Biopsies This study covers the world outlook for breast cancer liquid biopsies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question ... Read More

    • The 2025-2030 World Outlook for Immunoassays for Cancer and Tumor Profiling

      The 2025-2030 World Outlook for Immunoassays for Cancer and Tumor Profiling This study covers the world outlook for immunoassays for cancer and tumor profiling across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), ... Read More

    • The 2025-2030 World Outlook for Leukemia Treatments

      The 2025-2030 World Outlook for Leukemia Treatments This study covers the world outlook for leukemia treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More

    • The 2025-2030 World Outlook for Chronic Myelogenous Leukemia Treatments

      The 2025-2030 World Outlook for Chronic Myelogenous Leukemia Treatments This study covers the world outlook for chronic myelogenous leukemia treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the ... Read More

    • The 2025-2030 World Outlook for Lung Cancer Surgeries

      The 2025-2030 World Outlook for Lung Cancer Surgeries This study covers the world outlook for lung cancer surgeries across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More

    • The 2025-2030 World Outlook for Leukemia Chemotherapy Therapeutics

      The 2025-2030 World Outlook for Leukemia Chemotherapy Therapeutics This study covers the world outlook for leukemia chemotherapy therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in ... Read More

    • The 2025-2030 World Outlook for Lung Cancer Therapeutics

      The 2025-2030 World Outlook for Lung Cancer Therapeutics This study covers the world outlook for lung cancer therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millio ... Read More

    • The 2025-2030 World Outlook for Basal Cell Carcinoma Surgeries

      The 2025-2030 World Outlook for Basal Cell Carcinoma Surgeries This study covers the world outlook for basal cell carcinoma surgeries across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in questio ... Read More

    • The 2025-2030 World Outlook for Cancer Supportive Care Products

      The 2025-2030 World Outlook for Cancer Supportive Care Products This study covers the world outlook for cancer supportive care products across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More

    • The 2025-2030 World Outlook for Hematological Cancers

      The 2025-2030 World Outlook for Hematological Cancers This study covers the world outlook for hematological cancers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More

2 3 4 5 6 7 8 9 10 11

Research Assistance

Live help

Join Alert Me Now!

Sign Up

Find out more on our blog
Cookie Settings